Key result
Acute carotid stent thrombosis is a rare but catastrophic event, and while there is no standard treatment regimen, dual antiplatelet therapy is typically recommended before and after stenting.
This commentary highlights the importance of dual antiplatelet therapy in preventing acute carotid stent thrombosis and discusses carotid endarterectomy as a treatment for refractory cases.
In this commentary on the article entitled "Acute carotid stent thrombosis: A case report and literature review", the key points of the article are discussed. Acute carotid stent thrombosis (ACST) in the setting of carotid artery stenting (CAS) represents a rare but potentially catastrophic event. There is a wide range of treatment options available, including carotid endarterectomy, which is generally recommended for cases of refractory ACST. While there is no standard treatment regimen, dual antiplatelet therapy is typically recommended both before and after CAS to reduce risk of ACST.
No takes yet. Share an insight, caveat, or question.
Willman et al. (2023) conducted an editorial in Acute carotid stent thrombosis. Dual antiplatelet therapy was evaluated. Acute carotid stent thrombosis is a rare but catastrophic event, and while there is no standard treatment regimen, dual antiplatelet therapy is typically recommended before and after stenting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: